Eli Lilly & Co. (LLY)

• Annual Data
• Quarterly Data

Eli Lilly & Co., Common-Size Consolidated Income Statement (quarterly data)

Based on: 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-05-01), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-30), 10-Q (filing date: 2015-04-30), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-07-28), 10-Q (filing date: 2014-04-28), 10-K (filing date: 2014-02-19), 10-Q (filing date: 2013-10-30), 10-Q (filing date: 2013-07-26), 10-Q (filing date: 2013-04-26).

Item	Description	The company
Operating income (loss)	The net result for the period of deducting operating expenses from operating revenues.	Eli Lilly & Co.’s operating income (loss) as a percentage of revenue declined from Q1 2018 to Q2 2018 but then increased from Q2 2018 to Q3 2018 not reaching Q1 2018 level.
Income before income taxes	Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.	Eli Lilly & Co.’s income before income taxes as a percentage of revenue declined from Q1 2018 to Q2 2018 but then increased from Q2 2018 to Q3 2018 not reaching Q1 2018 level.
Net income (loss)	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Eli Lilly & Co.’s net income (loss) as a percentage of revenue declined from Q1 2018 to Q2 2018 but then increased from Q2 2018 to Q3 2018 not reaching Q1 2018 level.